Brind.

MiMedx reported that its free cash flow significantly exceeded statutory profit and its accrual ratio was negative as of August 7, 2025.

1 report, 1 independent Updated Aug 7
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

MiMedx reported that its free cash flow significantly exceeded statutory profit and its accrual ratio was negative as of August 7, 2025.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

  • MiMedx

    biomedical company based in Marietta, Georgia, founded in 2008

    Nothing else this week.

Coverage

Newest first; wire copies grouped
  • Simply Wall St.There May Be Reason For Hope In MiMedx Group's (NASDAQ:MDXG) Disappointing Earnings The market was pleased with the recent earnings report from MiMedx Group, Inc. (NASDAQ:MDXG), despite the profit nu